Celcuity Inc
Veridion Score
Composite trend over time
Why is CELC moving today?
Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors. Its candidate, gedatolisib, is a kinase inhibitor of the PI3K/AKT/mTOR (PAM) pathway, binding all class I PI3K isoforms and mTORC1/2, offering comprehensive inhibition with a mechanism and pharmacokinetics differentiated from other therapies. The Phase 3 VIKTORIA-1 trial, evaluating gedatolisib with fulvestrant, with or without palbociclib, in HR+/HER2- breast cancer, has completed enrollment and reported results for PIK3CA WT tumors, with cohort 2 (PIK3CA MT) also enrolled. Phase 3 VIKTORIA-2 and Phase 1b/2 CELC-G-201 trials, evaluating combinations in endocrine-resistant HR+/HER2- breast cancer and metastatic castration-resistant prostate cancer, are ongoing.
Real vendor fields plus Veridion-computed history. Missing fields stay blank.
Warehouse intelligence for CELC.
CELC insider activity
Celcuity Inc
2 insiders bought in the last 90 days
Net selling: -$4.0M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-04 | 2026-06-02 | Laing Lance G. | Insider | buy | $9.89 | 1,000 | 1,251,000 | $10K | SEC Form 4 |
| 2026-05-06 | 2026-05-04 | Buller Richard E | Insider | sell | $143.24 | 365 | 6,760 | $52K | SEC Form 4 |
| 2026-05-06 | 2026-05-04 | Buller Richard E | Insider | sell | $142.04 | 2,825 | 7,125 | $401K | SEC Form 4 |
| 2026-05-06 | 2026-05-04 | Buller Richard E | Insider | sell | $141.03 | 2,301 | 9,950 | $325K | SEC Form 4 |
| 2026-05-06 | 2026-05-04 | Buller Richard E | Insider | sell | $139.58 | 1,670 | 12,251 | $233K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 31 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moCELC contract awards, year to date.
Public federal awards linked to this ticker.
CELC lobbying filings, year to date.
Registered lobbying filings matched to Celcuity Inc.